H5112 would prohibit discrimination based on genetic test results or genetic information in certain insurance products in Massachusetts, including life insurance, accident and sickness insurance, and long-term care insurance. The bill amends existing insurance law to bar insurers from using genetic information to set rates, restrict coverage length, or otherwise discriminate against applicants or policyholders. It also clarifies that applicants cannot be required to answer questions about genetic testing, and if they voluntarily provide genetic information or it appears in medical records, insurers still may not use it to determine policy terms.
The bill also adds enforcement language giving the Commissioner of Insurance authority to investigate suspected violations, hold hearings under chapter 176D, and order insurers to stop prohibited practices and pay penalties. In effect, it strengthens consumer protections around genetic privacy and limits how insurers may collect and use hereditary health information when underwriting coverage.
Impact
If enacted, the bill would change Massachusetts insurance law by expanding and clarifying protections against genetic discrimination in underwriting and policy administration. It would affect insurers, insurance brokers, and applicants for life, disability/accident and sickness, and long-term care coverage by restricting questions about genetic testing and prohibiting the use of genetic information in setting terms of coverage. It would also reinforce the Commissioner of Insurance’s enforcement powers under chapter 176D.
Sentiment
The available record shows no committee transcript or vote history, so there is no documented floor or committee debate to gauge support or opposition. Based on the bill’s subject matter and structure, it appears to be a consumer-protection measure aimed at preventing misuse of sensitive health information, with an emphasis on privacy and fairness in insurance markets.
Contention
The main potential point of contention is the balance between consumer protections and insurers’ underwriting practices. Supporters would likely emphasize privacy, anti-discrimination, and access to coverage for people with inherited health risks, while insurers or industry stakeholders may be concerned about limits on risk assessment, application questions, and the use of medical records. The bill’s allowance for insurers to ask whether an applicant has taken a genetic test, while prohibiting any requirement to answer and barring use of the information in pricing or terms, may also be a focal point in discussion.